Influenza virus strain H5N1 clade 1 vaccine(sanofi pasteur)

N/A

Report date: 2022/08/29 20:00:24

Base Information

Drug NameInfluenza virus strain H5N1 clade 1 vaccine(sanofi pasteur)
Drug Alias NameInactivated Influenza A/H5N1 Vaccine (sanofi pasteur)
ClassificationVaccines > Development/production technology > Inactivated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A